Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Antibiotics After Cesarean
NCT03187106Phase 1Completed
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- Aug 2017
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in surgical site infection (SSI) comparing Cephalexin + Metronidazole with Placebo (2 arms). Primary endpoint: Surgical site infection. Started Aug 2017; status: completed.
02
Drugs
cefalexinmetronidazole
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT03187106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03187106.